Heart disease is the leading cause of death in the United States[1] equally impacting all. Being Women’s Health Week, we want to highlight the impact heart disease has on the livelihood of women and what new developments there are in the life sciences innovation world that would reduce the impact it has on society.

One of the best approaches to the risk reduction of heart conditions is healthy living. Moderating our eating and drinking habits along with physical activity can have a tremendously positive effect on the quality of life of people[2]. However, hereditary factors can increase the risk of heart conditions regardless of lifestyle. New research[3] into health diseases has prioritized understanding the different symptoms and lived experiences of women and women of color suffering from the ailments of heart disease. While similar symptoms can be identified across patients with heart conditions, the nuanced differences between men and women can increase the knowledge for treatment innovation. In response to this, the FDA’s Office of Women’s Health (OWH)[4] has funded research to understand sex differences in drug and device development hoping that this will create awareness of gender bias in how drugs and devices are designed.

For medical device manufacturers, implicit gender bias is not new. Reports[5] have identified the implicit bias in two major conceptual design inputs: the mechanics and computational. This is an alarming discovery that has tasked manufacturers to rethink the clinical studies process and data collection used for training machine learning algorithms. With this newfound funding from OWH, there has never been a better time for manufacturers to pioneer new technology for heart diseases that take into consideration gender differences.

The challenges of auditing for gender bias in drug and device development can present obstacles. EMMA can support this by developing processes and bringing forth evidence of substantive equivalence in the continuous improvement of devices and clinical investigations for drugs that want to be audited for gender bias in FDA submissions. The demand for medical innovation for life-saving heart disease medicines and devices has never been so high. Similarly, the demand for equality. EMMA can help marriage the two demands, give us a call at 248-987-4497 or email us at info@emmainternational.com today to learn more.


[1] “Heart Disease Facts.” Center for Disease Control and Prevention (CDC). Heart Disease Facts | cdc.gov

[2]  “Know your Risk for Heart Disease.” Center for Disease Control and Prevention (CDC). Know Your Risk for Heart Disease | cdc.gov

[3] “Gender matters: Heart disease risk in women.” Harvard Medical School. 2017. Gender matters: Heart disease risk in women – Harvard Health

[4] Completed OWH-Funded Research Projects on Cardiovascular Disease. FDA. Completed OWH-funded Research Projects on Cardiovascular Disease | FDA

[5] “Fixing Medical Devices that are Biased against Race or Gender.” Wallis, Claudia. 2021.  Fixing Medical Devices That Are Biased against Race or Gender – Scientific American

Emma International

Emma International

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...
Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

Ready to learn more about working with us?

Pin It on Pinterest

Share This